TE
NRIX icon

Tema ETFs’s Nurix Therapeutics NRIX Stock Holding History

Tema ETFs’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-76,625
Closed -$1.45M – 585
2025
Q4 		$1.45M Buy
76,625
+31,893
+71% +$458K 0.11% 189
2025
Q3 		$413K Sell
44,732
-36,380
-45% -$378K 0.03% 408
2025
Q2 		$924K Buy
81,112
+21,966
+37% +$237K 0.25% 113
2025
Q1 		$703K Buy
59,146
+36,589
+162% +$612K 0.21% 103
2024
Q4 		$425K Buy
+22,557
New +$517K 0.18% 107

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Tema ETFs's NRIX Position: Q1 2026 in Review

Tema ETFs sold out of Nurix Therapeutics (NRIX) in Q1 2026, closing a stake of 76,625 shares — an estimated $1.45M sold.

Tema ETFs first reported a position in NRIX in Q4 2024 and held it in 5 quarters. The position peaked at $1.45M in Q4 2025. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • Tema ETFs reported no remaining Nurix Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Tema ETFs sold 76,625 Nurix Therapeutics shares in Q1 2026, an estimated $1.45M.
  • Tema ETFs first reported a position in Nurix Therapeutics in Q4 2024 and held it in 5 quarters.
  • Tema ETFs's Nurix Therapeutics position peaked at $1.45M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on Tema ETFs's 13F filing for Q1 2026, filed 15 Apr 2026.